Connective Tissue Diseases and Lung Manifestations

Recruiting now

Conditions studied: Connective Tissue Diseases, Interstitial Lung Disease, Systemic Sclerosis

In brief

Despite a number of prospective studies already initiated in the past years, the current epidemiology and course of interstitial lung disease (ILD) and pulmonary hypertension (PH) in patients with connective tissue disease (CTD) is still not well defined, particularly regarding its prevalence, incidence and the management of a broad spectrum of disease presentations. Major challenges include the identification of patients with progressive disease, the appropriate time point of therapeutic intervention and the underlying driver of disease (inflammatory or pro-fibrotic stimulus or both?). To address these issues in Western Austria, a progressive registry of patients with CTD exploring routine clinical and pathophysiological characteristics of ILD and PH will be conducted. This multidisciplinary, prospective and observational registry aims to collect comprehensive clinical data on incidence, prevalence and course of disease regarding all PH and ILD presentations in a real-world setting.

Key facts

Study ID: NCT04095351
Run by: Medical University Innsbruck
People needed: 120
Starts: 2019-12-09
Expected to finish: 2034-10-01
Last updated by the study team: 2020-05-27

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

The inclusion criteria are adult patients (≥18 years) diagnosed with CTD with signed informed consent.

You may not qualify if…

Exclusion criteria are patients with a serious co-morbidity interfering with the course of interstitial lung disease or pulmonary hypertension.

Where it is running

Medical University Innsbruck, Department of Internal Medicine II — Innsbruck, Austria (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.